The Effect of Changing Angle of Bed on Pain Severity and Vascular Complications Among Cardiac Catheterization Patients

September 13, 2022 updated by: sara sobh mohamed ramadan ellawindy, Mansoura University

Faculty of Nursing- Critical Care and Emergency Nursing Department

Care of CVD patients in Egypt is very complex and sensitive because of the high incidence and high mortality rate. In 2019, approximately 18.6 million deaths were attributed to CVD globally. As a consequence, cardiac catheterization remains the criterion standard for evaluation of CAD.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

This study will be conducted in three phases; preparation, implementation, and evaluation.

  1. Preparation phase

    • Ethical approval will be obtained from the Research Ethics Committee (REC) of the Faculty of Nursing - Mansoura University.
    • Content validity of the developed tool will be reviewed by a jury of five experts in the study field and the suggestions of the jury members will be considered.
    • The reliability of this tool will be assessed also by using Cronbach's Alpha Test.
  2. Implementation phase

    • An initial assessment will be carried out for all patients to confirm that they are free from the exclusion criteria.
    • Patients will be assigned into two groups: intervention group and control group, 41 patients for each group.
    • Before the cardiac catheterization procedure: patients' demographic characteristics and health relevant data will be collected on the first day of admission using part I and part II of tool I.
    • In both groups after cardiac catheterization procedure: the sheath will be removed immediately by the nurse.
    • In the control group: positioning the patients in supine for 6 hours and the affected leg was straight and immobilized.
    • In the intervention group: the researcher will change angle of bed from 15° to 45°.
    • The severity of pain will be assessed by using part III of tool I for five times starting immediately after sheath removal.
    • Vascular complications monitoring scales will be assessed by using tool III for five times starting immediately after sheath removal.
  3. Evaluation phase This phase aims to investigate the effect of changing angle of bed on pain severity and vascular complications for both groups.

Study Type

Interventional

Enrollment (Anticipated)

82

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Adult patient ≥ 18 years old of both sexes.

  • Conscious patients admitted to the CCU after diagnostic or therapeutic cardiac catheterization.
  • Patients who will have femoral artery catheterization.
  • Patients who will have normal prothrombin time and partial thromboplastin time.

Exclusion Criteria:

  • Patients who have previous surgery in the iliac or femoral artery.

    • Patients who have chronic back pain.
    • Patients who have an active bleed¬ing, hematoma and ecchymosis from insertion site prior to the sheath withdrawal.
    • Patient who take anti-coagulant drugs and analgesic therapy within the previous 24 hours before the procedure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention group
the researcher will change angle of bed from 15° to 45°. The severity of pain will be assessed for five times starting immediately after sheath removal. Vascular complications monitoring scales will be assessed I for five times starting immediately after sheath removal.
Before the cardiac catheterization procedure: patients' demographic characteristics and health relevant data will be collected on the first day of admission. the researcher will change angle of bed from 15° to 45°.
No Intervention: control group
positioning the patients in supine for 6 hours and the affected leg was straight and immobilized. The severity of pain will be assessed for five times starting immediately after sheath removal. Vascular complications monitoring scales will be assessed I for five times starting immediately after sheath removal.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changing pain severity according to the numerical pain scale
Time Frame: 6 hours
Patients who receive changing angle of bed after cardiac catheterization will have less pain severity according to the numerical pain scale than those who will receive hospital routine care.
6 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
reduction of vascular complications according to the vascular complications monitoring scales
Time Frame: 6 hours
The vascular complications will be decreased after changing angle of bed among cardiac catheterization patients according to the vascular complications monitoring scales
6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 30, 2022

Primary Completion (Anticipated)

January 30, 2023

Study Completion (Anticipated)

February 28, 2023

Study Registration Dates

First Submitted

August 25, 2022

First Submitted That Met QC Criteria

September 13, 2022

First Posted (Actual)

September 14, 2022

Study Record Updates

Last Update Posted (Actual)

September 14, 2022

Last Update Submitted That Met QC Criteria

September 13, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Ref.no.p 0.0237

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Catheterization

Clinical Trials on changing angle of bed

Subscribe